DarioHealth Future Growth
Future criteria checks 0/6
DarioHealth is forecast to grow earnings and revenue by 2.1% and 1.4% per annum respectively. EPS is expected to grow by 9.4% per annum. Return on equity is forecast to be -2.7% in 3 years.
Key information
2.1%
Earnings growth rate
9.4%
EPS growth rate
Healthcare Services earnings growth | 33.1% |
Revenue growth rate | 1.4% |
Future return on equity | -2.7% |
Analyst coverage | Low |
Last updated | 29 Jan 2025 |
Recent future growth updates
Recent updates
Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch
Nov 17A Piece Of The Puzzle Missing From DarioHealth Corp.'s (NASDAQ:DRIO) 27% Share Price Climb
Oct 03Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 30% Lower
Aug 09Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues
May 31DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 16Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook
Nov 06Is DarioHealth (NASDAQ:DRIO) Using Debt Sensibly?
Oct 07Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 28% Lower
Aug 16Need To Know: Analysts Just Made A Substantial Cut To Their DarioHealth Corp. (NASDAQ:DRIO) Estimates
Aug 15DarioHealth Corp. (NASDAQ:DRIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 13DarioHealth (NASDAQ:DRIO) Is Using Debt Safely
Oct 05Need To Know: The Consensus Just Cut Its DarioHealth Corp. (NASDAQ:DRIO) Estimates For 2022
Aug 24DarioHealth Q2 2022 Earnings Preview
Aug 12DarioHealth: Paying 1.6x Equity Value For Cash Flows Priced Into The Future
Jul 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 47 | -29 | -9 | -13 | 1 |
12/31/2026 | 41 | -38 | -13 | -15 | 2 |
12/31/2025 | 36 | -42 | -11 | -10 | 3 |
12/31/2024 | 27 | -42 | -20 | -23 | 3 |
9/30/2024 | 23 | -32 | -39 | -39 | N/A |
6/30/2024 | 19 | -36 | -41 | -40 | N/A |
3/31/2024 | 19 | -49 | -39 | -39 | N/A |
12/31/2023 | 20 | -55 | -31 | -30 | N/A |
9/30/2023 | 24 | -57 | -32 | -31 | N/A |
6/30/2023 | 27 | -58 | -33 | -33 | N/A |
3/31/2023 | 27 | -58 | -35 | -35 | N/A |
12/31/2022 | 28 | -60 | -48 | -48 | N/A |
9/30/2022 | 27 | -65 | -56 | -55 | N/A |
6/30/2022 | 26 | -73 | -57 | -57 | N/A |
3/31/2022 | 25 | -72 | -58 | -58 | N/A |
12/31/2021 | 21 | -68 | -51 | -50 | N/A |
9/30/2021 | 17 | -58 | -42 | -42 | N/A |
6/30/2021 | 13 | -43 | -34 | -33 | N/A |
3/31/2021 | 10 | -32 | -24 | -24 | N/A |
12/31/2020 | 8 | -33 | -18 | -18 | N/A |
9/30/2020 | 7 | -31 | -14 | -14 | N/A |
6/30/2020 | 7 | -26 | -13 | -13 | N/A |
3/31/2020 | 7 | -27 | -16 | -16 | N/A |
12/31/2019 | 8 | -21 | -16 | -16 | N/A |
9/30/2019 | 7 | -19 | -16 | -16 | N/A |
6/30/2019 | 7 | -20 | -16 | -16 | N/A |
3/31/2019 | 8 | -21 | -13 | -13 | N/A |
12/31/2018 | 7 | -18 | -12 | -11 | N/A |
9/30/2018 | 7 | -17 | -11 | -10 | N/A |
6/30/2018 | 7 | -16 | N/A | -10 | N/A |
3/31/2018 | 6 | -14 | N/A | -10 | N/A |
12/31/2017 | 5 | -16 | N/A | -11 | N/A |
9/30/2017 | 4 | -16 | N/A | -10 | N/A |
6/30/2017 | 4 | -14 | N/A | -10 | N/A |
3/31/2017 | 3 | -14 | N/A | -9 | N/A |
12/31/2016 | 3 | -12 | N/A | -8 | N/A |
9/30/2016 | 2 | -9 | N/A | -9 | N/A |
6/30/2016 | 2 | -10 | N/A | -7 | N/A |
3/31/2016 | 1 | -8 | N/A | -7 | N/A |
12/31/2015 | 1 | -7 | N/A | -6 | N/A |
9/30/2015 | 1 | -9 | N/A | -7 | N/A |
6/30/2015 | 0 | -14 | N/A | -7 | N/A |
3/31/2015 | 0 | -15 | N/A | -8 | N/A |
12/31/2014 | 0 | -16 | N/A | -9 | N/A |
9/30/2014 | N/A | -13 | N/A | -8 | N/A |
6/30/2014 | N/A | -10 | N/A | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DRIO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DRIO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DRIO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DRIO's revenue (1.4% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: DRIO's revenue (1.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DRIO is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 00:39 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DarioHealth Corp. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Steven Halper | Cantor Fitzgerald & Co. |
Raghuram Selvaraju | Rodman & Renshaw, LLC |
David Grossman | Stifel, Equities Research |